| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/14/2014 | CA2342243C Stable liquid formulations of botulinum toxin |
| 01/09/2014 | WO2014008474A1 U1 snrnp regulates gene expression and modulates oncogenicity |
| 01/09/2014 | WO2014008448A1 Quantitative assessment of human t-cell repertoire recovery after allogeneic hematopoietic stem cell transplantation |
| 01/09/2014 | WO2014008242A1 The use of interleukin-11 to protect against ischemia and reperfusion injury |
| 01/09/2014 | WO2014008054A2 Novel insecticidal proteins and methods for their use |
| 01/09/2014 | WO2014007584A1 Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban |
| 01/09/2014 | WO2014007402A1 Differentiation marker for and differentiation control for ocular cells |
| 01/09/2014 | WO2014007369A1 Fgfr2 fusion gene |
| 01/09/2014 | WO2014006502A1 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | WO2014006452A2 Rapid alkalinization factor peptides for delivery of nucleic acid molecules into cells |
| 01/09/2014 | WO2014006253A1 Composition for treating bacterial infections of the skin and mucous membranes |
| 01/09/2014 | WO2014006226A1 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO |
| 01/09/2014 | WO2014006225A1 Fluorescent fusion polypeptide, biosensor comprising said polypeptide and uses thereof |
| 01/09/2014 | WO2014006203A1 Engineered clostridium strain for butanol production |
| 01/09/2014 | WO2014006087A1 Extracellular matrix heparin-binding domains |
| 01/09/2014 | WO2014006082A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | WO2014006025A2 Marker of pathogenicity in salmonella |
| 01/09/2014 | WO2014005959A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | WO2014005596A1 Modified payload molecules and their interactions and uses |
| 01/09/2014 | WO2014005499A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 01/09/2014 | WO2014005466A1 Product for mitigating iron deficiency anemia and method for preparing same |
| 01/09/2014 | WO2014005219A1 Intracellular protein delivery |
| 01/09/2014 | WO2013151666A3 Modified polynucleotides for the production of biologics and proteins associated with human disease |
| 01/09/2014 | WO2013132452A3 Neisseria meningitidis compositions and methods thereof |
| 01/09/2014 | US20140011978 Extracellular matrix heparin-binding domains |
| 01/09/2014 | US20140011747 Syndecan peptides and polypeptides as inhibitors of cancer |
| 01/09/2014 | US20140011746 Syndecan peptides and polypeptides as inhibitors of cancer |
| 01/09/2014 | US20140011742 Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same |
| 01/09/2014 | US20140011740 Modified animal erythropoietin polypeptides and their uses |
| 01/09/2014 | US20140011738 Glucagon analogs exhibiting gip receptor activity |
| 01/09/2014 | US20140011735 Antiviral composition |
| 01/09/2014 | US20140011733 Combination of acylated glucagon analogues with insulin analogues |
| 01/09/2014 | US20140011732 Peptides Derivatized with A-B-C-D- and their Therapeutical Use |
| 01/09/2014 | US20140011731 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 01/09/2014 | US20140011728 Long-acting il-1 receptor antagonists |
| 01/09/2014 | US20140011700 Three-dimensional structure of h1n1 nucleoprotein in complex with antiviral compounds |
| 01/09/2014 | US20140011272 Fluorescent proteins and genes encoding them |
| 01/09/2014 | US20140011259 Protein Variants Having Modified Immunogenicity |
| 01/09/2014 | US20140011234 Enhanced protein expression in bacillus |
| 01/09/2014 | US20140011216 Engineered pertactin variants for vaccine use |
| 01/09/2014 | US20140011188 Methods for producing virus particles with simplified glycosylation of surface proteins |
| 01/09/2014 | US20140010864 Liposomes for protection against toxic compounds |
| 01/09/2014 | US20140010863 Liposomes for protection against toxic compounds |
| 01/09/2014 | US20140010850 Albumin fibers and fabrics and methods of generating and using same |
| 01/09/2014 | US20140010843 Method of detoxification |
| 01/09/2014 | US20140010836 Antigenic gly1 polypeptides |
| 01/09/2014 | US20140010835 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO |
| 01/09/2014 | US20140010832 Protein-binding peptide isolated from placenta growth factor |
| 01/09/2014 | US20140010831 Her-2 peptides |
| 01/09/2014 | US20140010816 Treatment and prevention of malaria |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | US20140010786 Use of hepatocyte nuclear factor 1a in preparation of drug for treating malignant solid tumor disease |
| 01/09/2014 | US20140007547 Method for inactivation/removal of coagulation factors by precipitation |
| 01/09/2014 | CA2878344A1 Complexes of cytomegalovirus proteins |
| 01/09/2014 | CA2878322A1 Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery |
| 01/09/2014 | CA2878291A1 Quantitative assessment of human t-cell repertoire recovery after allogeneic hematopoietic stem cell transplantation |
| 01/09/2014 | CA2878263A1 Novel insecticidal proteins and methods for their use |
| 01/09/2014 | CA2878126A1 Fluorescent fusion polypeptide, biosensor comprising said polypeptide and uses thereof |
| 01/09/2014 | CA2878100A1 Conjugates containing sequences from placenta growth factor and their use as components of biomaterials and in medicine |
| 01/09/2014 | CA2877948A1 Paramyxovirus and methods of use |
| 01/09/2014 | CA2877384A1 Intracellular protein delivery |
| 01/09/2014 | CA2876541A1 Mutant fragments of ospa and methods and uses relating thereto |
| 01/08/2014 | EP2682465A1 Hydrogen peroxide resistance-imparting gene and method for using same |
| 01/08/2014 | EP2682464A1 Fibrinogen-producing transgenic silkworm |
| 01/08/2014 | EP2682463A1 Bacteriocin derived from lactobacillus rhamnosus |
| 01/08/2014 | EP2682407A1 Hemoglobin-albumin complex, and artificial plasma expander and artificial oxygen carrier, each containing same |
| 01/08/2014 | EP2682406A2 Fusion protein comprising albumin and a retinol-binding protein |
| 01/08/2014 | EP2682405A1 Tumor necrosis factor- humanized antibody |
| 01/08/2014 | EP2682403A2 Genes and methods for increasing disease resistance in plants |
| 01/08/2014 | EP2682402A1 Ice crystallization inhibitor derived from plant seed |
| 01/08/2014 | EP2682401A1 Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof |
| 01/08/2014 | EP2682128A1 Medicinal agent for inhibiting metastasis of malignant tumor |
| 01/08/2014 | EP2681559A1 Peptide-lipid constructs and their use in a fc-function assay |
| 01/08/2014 | EP2681323A1 Plants having enhanced yield-related traits and producing methods thereof |
| 01/08/2014 | EP2681322A1 Plants having enhanced yield-related traits and producing methods thereof |
| 01/08/2014 | EP2681316A1 Isolated laminin-421 |
| 01/08/2014 | EP2681308A1 Protein expression |
| 01/08/2014 | EP2681280A1 Biomaterial, method for making the biomaterial and uses of the same |
| 01/08/2014 | EP2681246A2 Tetravalent and mixed head bivalent dengue vaccine |
| 01/08/2014 | EP2681245A1 Multivalent heteromultimer scaffold design and constructs |
| 01/08/2014 | EP2681238A2 Apoptosis-inducing molecules and uses therefor |
| 01/08/2014 | EP2681237A1 Antagonistic dr3 ligands |
| 01/08/2014 | EP2681236A2 Process of preparing guanylate cyclase c agonists |
| 01/08/2014 | EP2681235A1 Hydrogen bond surrogate macrocycles as modulators of ras |
| 01/08/2014 | EP2681234A1 Powdery mildew resistance providing genes in cucumis melo |
| 01/08/2014 | EP2681233A1 Powdery mildew resistance providing genes in cucumis sativus |
| 01/08/2014 | EP2681232A1 Infectious bronchitis virus (ibv) spike protein as subunit vaccine |
| 01/08/2014 | EP2681231A1 Method for isolating osteopontin using concentrated feeds |
| 01/08/2014 | EP2681230A1 Method for isolating osteopontin using feeds containing cmp or casein species |
| 01/08/2014 | EP2681226A1 Novel compounds with photoluminescnce properties and applications thereof |
| 01/08/2014 | EP2680883A1 Pcsk9 vaccine |
| 01/08/2014 | EP2680876A1 Gla-domainless factor xa for treating haemophilia a or b with or without inhibitor |
| 01/08/2014 | EP2680875A1 Coagulation factor-targeting to tlt-1 on activated platelets |
| 01/08/2014 | EP2680874A2 Edn3-like peptides and uses thereof |
| 01/08/2014 | EP2680871A2 Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | EP2680867A2 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses |
| 01/08/2014 | EP2680809A1 Composition comprising peroxisome proliferator-activated receptor-gamma (ppar) |
| 01/08/2014 | EP2510951A9 Molecular probe for imaging of pancreatic islet, and use thereof |
| 01/08/2014 | CN1826354B Methods for preventing and treating alzheimer's disease (AD) |
| 01/08/2014 | CN103502456A Plants having enhanced yield-related traits and producing methods thereof |